A scoping review of factors associated with antimicrobial-resistant Campylobacter species infections in humans

Abstract Human infection with antimicrobial-resistant Campylobacter species is an important public health concern due to the potentially increased severity of illness and risk of death. Our objective was to synthesise the knowledge of factors associated with human infections with antimicrobial-resistant strains of Campylobacter. This scoping review followed systematic methods, including a protocol developed a priori. Comprehensive literature searches were developed in consultation with a research librarian and performed in five primary and three grey literature databases. Criteria for inclusion were analytical and English-language publications investigating human infections with an antimicrobial-resistant (macrolides, tetracyclines, fluoroquinolones, and/or quinolones) Campylobacter that reported factors potentially linked with the infection. The primary and secondary screening were completed by two independent reviewers using Distiller SR®. The search identified 8,527 unique articles and included 27 articles in the review. Factors were broadly categorised into animal contact, prior antimicrobial use, participant characteristics, food consumption and handling, travel, underlying health conditions, and water consumption/exposure. Important factors linked to an increased risk of infection with a fluoroquinolone-resistant strain included foreign travel and prior antimicrobial use. Identifying consistent risk factors was challenging due to the heterogeneity of results, inconsistent analysis, and the lack of data in low- and middle-income countries, highlighting the need for future research.

[1]  H. Wieden,et al.  Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada , 2021, Frontiers in Public Health.

[2]  L. Molinier,et al.  Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture , 2021, Antimicrobial Resistance & Infection Control.

[3]  V. Solomon,et al.  The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries. A systematic review and meta-analysis , 2021, Archives of Public Health.

[4]  T. Griffiths,et al.  Review of Antibiotic Use in Crops, Associated Risk of Antimicrobial Resistance and Research Gaps , 2020 .

[5]  Jessica C. Chen,et al.  Comparison of Molecular Subtyping and Antimicrobial Resistance Detection Methods Used in a Large Multistate Outbreak of Extensively Drug-Resistant Campylobacter jejuni Infections Linked to Pet Store Puppies , 2020, Journal of Clinical Microbiology.

[6]  C. Gerba,et al.  Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper , 2020, American Journal of Infection Control.

[7]  B. Marshall,et al.  An analysis of antibiotic prescribing practices for enteric bacterial infections within FoodNet Canada sentinel sites. , 2020, The Journal of antimicrobial chemotherapy.

[8]  T. V. Van Boeckel,et al.  Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel. , 2019, Journal of travel medicine.

[9]  P. Coyte,et al.  When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada , 2019 .

[10]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[11]  Ben A. Smith,et al.  Factors potentially linked with the occurrence of antimicrobial resistance in selected bacteria from cattle, chickens and pigs: A scoping review of publications for use in modelling of antimicrobial resistance (IAM.AMR Project) , 2018, Zoonoses and public health.

[12]  L. Price,et al.  Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Pruckler,et al.  Features of illnesses caused by five species of Campylobacter, Foodborne Diseases Active Surveillance Network (FoodNet) – 2010–2015 , 2017, Epidemiology and Infection.

[14]  A. Facciolà,et al.  Campylobacter: from microbiology to prevention , 2017, Journal of preventive medicine and hygiene.

[15]  E. J. Threlfall,et al.  Public health risk of antimicrobial resistance transfer from companion animals. , 2016, The Journal of antimicrobial chemotherapy.

[16]  S. Essack,et al.  Antibiotic Resistance in the Food Chain: A Developing Country-Perspective , 2016, Front. Microbiol..

[17]  J. Rudrik,et al.  Antimicrobial Susceptibility Profiles of Human Campylobacter jejuni Isolates and Association with Phylogenetic Lineages , 2016, Front. Microbiol..

[18]  P. Pilon,et al.  Long-Lasting Outbreak of Erythromycin- and Ciprofloxacin-Resistant Campylobacter jejuni Subspecies jejuni From 2003 to 2013 in Men Who Have Sex With Men, Quebec, Canada. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Aarti Sharma,et al.  Analysis of Resistance to Antimicrobials and Presence of Virulence/Stress Response Genes in Campylobacter Isolates from Patients with Severe Diarrhoea , 2015, PloS one.

[20]  S. McEwen,et al.  Estimating the number of human cases of ceftiofur-resistant Salmonella enterica serovar Heidelberg in Québec and Ontario, Canada. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Rajić,et al.  A scoping review of scoping reviews: advancing the approach and enhancing the consistency , 2014, Research synthesis methods.

[22]  Nadine Oosmanally,et al.  Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005-2011. , 2014, American journal of public health.

[23]  L. Bester Antibiotic resistance in the food chain : a case study of Campylobacter spp. in poultry. , 2013 .

[24]  Andrea Nesbitt,et al.  Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. , 2013, Foodborne pathogens and disease.

[25]  Y. Carmeli,et al.  Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance , 2013, Clinical Microbiology Reviews.

[26]  T. Hald,et al.  Antimicrobial use: a risk factor or a protective factor for acquiring campylobacteriosis? , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  E. Bottieau,et al.  EPIDEMIOLOGY AND OUTCOME OF SHIGELLA, SALMONELLA AND CAMPYLOBACTER INFECTIONS IN TRAVELLERS RETURNING FROM THE TROPICS WITH FEVER AND DIARRHOEA , 2011, Acta clinica Belgica.

[28]  M. Hänninen,et al.  Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection , 2010, Gut pathogens.

[29]  M. Evans,et al.  Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales. , 2009, The Journal of antimicrobial chemotherapy.

[30]  E. Nielsen,et al.  Trends in occurrence of antimicrobial resistance in Campylobacter jejuni isolates from broiler chickens, broiler chicken meat, and human domestically acquired cases and travel associated cases in Denmark. , 2009, International journal of food microbiology.

[31]  Qijing Zhang,et al.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence. , 2009, Future microbiology.

[32]  F. Mégraud,et al.  Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. , 2008, The Journal of infectious diseases.

[33]  T. Wassenaar,et al.  Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. , 2007, International journal of antimicrobial agents.

[34]  David H Lloyd,et al.  Reservoirs of antimicrobial resistance in pet animals. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  G. Jhangri,et al.  Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta , 2007, Epidemiology and Infection.

[36]  W. van Pelt,et al.  Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands: an overview of 2000-2004. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  J. Giesecke,et al.  A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  U. Rao,et al.  Prevalence of Campylobacter jejuni and enteric bacterial pathogens among hospitalized HIV infected versus non-HIV infected patients with diarrhoea in southern India , 2007, Scandinavian journal of infectious diseases.

[39]  Y. Carmeli,et al.  The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance , 2005, Infection Control & Hospital Epidemiology.

[40]  Y. Carmeli,et al.  Impact of Severity of Illness Bias and Control Group Misclassification Bias in Case-Control Studies of Antimicrobial-Resistant Organisms , 2005, Infection Control & Hospital Epidemiology.

[41]  K. Mølbak,et al.  Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. , 2005, The Journal of infectious diseases.

[42]  N. Marano,et al.  Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. , 2004, The Journal of infectious diseases.

[43]  F. Aarestrup,et al.  Quinolone-resistant Campylobacter Infections: Risk Factors and Clinical Consequences , 2004, Emerging infectious diseases.

[44]  A. Adesiyun,et al.  Prevalence and antimicrobial resistance of Salmonella spp. in pet mammals, reptiles, fish aquarium water, and birds in Trinidad. , 2003, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[45]  S. Michaud,et al.  Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  A. Siitonen,et al.  Fluoroquinolone Resistance in Campylobacter jejuni Isolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel Destination , 2003, Emerging infectious diseases.

[47]  D. Tompkins,et al.  Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. , 2002, The Journal of antimicrobial chemotherapy.

[48]  D. Wareing,et al.  Characterisation of fluoroquinoloneresistant Campylobacter species isolated from human beings and chickens , 2002, Veterinary Record.

[49]  Y. Carmeli,et al.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  P. Hsueh,et al.  Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.

[51]  G. Jenkin,et al.  Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  M. F. Wenberg,et al.  Foodborne Diseases Active Surveillance Network (FoodNet) , 1998 .

[53]  I. Nachamkin,et al.  Campylobacter Species and Guillain-Barré Syndrome , 1998, Clinical Microbiology Reviews.

[54]  M. Blaser,et al.  Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). , 1988, Annals of internal medicine.

[55]  和典 橋本 Campylobacter と Campylobacteriosis , 1981 .

[56]  Prof Zoe Jordan JBI Manual for Evidence Synthesis , 2020 .

[57]  C. Dewey,et al.  Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario. , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[58]  L. Herman,et al.  Comparison of the frequency and the occurrence of antimicrobial resistance among C . jejuni and C . coli isolated from human infections , retail poultry meat and poultry in Zenica-Doboj Canton , Bosnia and Herzegovina , 2009 .

[59]  R. Tauxe,et al.  Epidemiology of Campylobacter jejuni Infections in Industrialized Nations , 2008 .

[60]  K. Levin Study design III: Cross-sectional studies , 2006, Evidence-Based Dentistry.

[61]  C. Dalton,et al.  Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. , 2003, Communicable diseases intelligence quarterly report.

[62]  P. Ringwald,et al.  Antimicrobial resistance. , 2001, Emerging infectious diseases.

[63]  Rian,et al.  QUINOLONE-RESISTANT CAMPYLOBACTER JEJUNI INFECTIONS IN MINNESOTA , 1992 – 1998 , 2022 .